JEOL Ltd.(6951) News

Announcement Regarding Results of Tender Offer for Own Shares and Completion of Share Repurchase

[Summary] Consolidated Financial Results for the Nine Months Ended December 31, 2025 (Under Japanese GAAP)

JEOL, Apr-Dec (Cumulative 3Q) Ordinary Profit Decreases by 11%

Announcement Regarding Share Repurchase and Tender Offer for Own Shares

[Summary] Consolidated Financial Results for the Six Months Ended September 30, 2025 (Under Japanese GAAP)

Notice Concerning Disposal of Treasury Shares as Stock Compensation

Notice Concerning Additional Contribution for Continuation of Performance-Linked Stock Compensation System

JEOL, First Half Ordinary Profit Decreases by 8%

Notice Concerning Establishment of Medical Equipment Subsidiary, Simplified Absorption-type Company Split, and Transfer of Subsidiary Shares

JEOL, Apr-Jun (1Q) Ordinary Profit Increases by 17%

[Summary] Consolidated Financial Results for the Three Months Ended June 30, 2025 (Under Japanese GAAP)

Notice Concerning Construction of New Buildings

Notice Concerning Recording of Extraordinary Losses (Loss on Valuation of Investment Securities)

Notice Concerning Continuation and Partial Revision of Performance-Linked Stock Compensation System

Formulation of Medium-Term Management Plan Evolving Growth 2.0 - A New Horizon -

Notice Concerning Dividends of Surplus (Increased Dividend)

[Summary] Consolidated Financial Results for the Fiscal Year Ended March 31, 2025 (Under Japanese GAAP)

JEOL, 29% Decrease in Ordinary Profit for The Current Fiscal Year, Increased Previous Year's Dividend by 14 yen, Plan to Continue the 106 yen Policy This Fiscal Year as Well

JEOL, Apr-Dec (Cumulative 3Q) Ordinary Profit Increases by 87%, Oct-Dec Ordinary Profit Increases by 3.1 times

JEOL Ltd., The Current Fiscal Year Ordinary Profit Revised Upward by 3%, Adds to Record High Profit Forecast, Dividend Revised Upward by 4 yen